Scars and Keloids Diagnosis
Scars and Keloids Diagnosis
A scar is identified by looking at it and asking about it. No blood test, scan or laboratory result tells a clinician what kind of scar is present. What the assessment does is place the scar on two axes at once. The first is kind: whether the tissue remains inside the outline of the original wound, which identifies a hypertrophic scar, or has advanced beyond it into uninjured skin, which identifies a keloid. The second is maturity: how far the process has run along the twelve to eighteen months it normally takes to settle. The history supplies what the surface cannot — how the wound came about, how long it took to close, whether it became infected, what treatment has already been tried and what each measure changed — and it is where a keloid tendency is usually recognised, from the site, the age at which the injury occurred and the family history.
The diagnosis is made from the history and the examination
It is worth saying plainly what a scar diagnosis consists of, because patients frequently arrive expecting an investigation that does not exist:
- There is no test that identifies a keloid. The diagnosis rests on the behaviour of the tissue and on the pattern of how the skin heals, both established by looking and by asking. Nobody is diagnosed from a scan or a blood sample.
- What the examination does is classify. It answers a small set of questions in order: is the tissue raised, does it stay inside the original wound, what is its colour and firmness, does it cross a joint or a free margin, and is the surrounding skin normal or inflamed and producing new lesions.
Why this is explained rather than assumed. A patient who expects a scan and is offered an examination may conclude that the assessment was superficial. Setting out what is being assessed, and what each observation decides, converts that impression into confidence.
The boundary: the observation that decides the most
Of everything the examination records, one comparison carries the most weight, and it is made by aligning the edge of the tissue with the edge of the original injury:
- Inside the outline means a hypertrophic scar. The tissue is confined to where the wound was. This is a scar still working through its remodelling, and it belongs to the group whose management is largely non-surgical and in which time is an ally.
- Beyond the outline means a keloid. Firm tissue in skin that was never injured is the defining feature. It changes the expectation, because a keloid does not settle on its own and because the same operation that suits a scar may make a keloid worse.
- When the answer is unclear, the history settles it. A scar that has quietly enlarged beyond its original site over a long period is behaving as a keloid however modest it looks, and it is treated as one.
Why so much rests on one comparison. Because it separates two conditions with different natural histories and different treatments. Getting it wrong in either direction is costly: treating a keloid as a scar leads to a recurrence, and treating a hypertrophic scar as a keloid leads to treatment more aggressive than the problem warrants.
Where the scar sits on its own timeline
The second axis is time, and it is assessed in the same way — by observation and by history rather than by measurement:
- Remodelling runs for twelve to eighteen months, and often longer. A scar is still under active change for well over a year in many cases, which is why a scar that is red and firm at six months is not yet a final result.
- Signs of activity are looked for rather than assumed. Continuing enlargement, a colour that has not begun to fade and firmness that is not softening all indicate that remodelling has not finished, and they argue for non-surgical measures and against operating.
Why the timeline is established before anything is planned. Because the commonest way a scar is made worse is by operating on it while it is still changing. The tissue removed is only part of the problem at that stage, and the new wound is made in skin that is actively laying down collagen.
Recording the symptoms, not just describing them
The symptoms are what treatment is most often judged against, and they are recorded in a way that allows a comparison later:
- Itch and pain are written down at the first visit. Whether a scar itches, how much and how often are the measures that will show whether a treatment worked. A symptom that was never recorded is one whose change cannot be demonstrated.
- Function is measured where a joint or a free margin is involved. The range of movement of the joint, or the completeness of eyelid closure, is recorded before treatment and compared afterwards, because in a contracture that is the outcome that matters.
- The patient’s own priority is part of the record. Appearance, itch, tightness and pain are not equally important to everyone, and which of them the patient most wants changed decides which measure is offered first.
Why a record rather than an impression. A scar changes slowly, and memory is a poor instrument for judging a change that takes months. What is written down at the start is what makes the result of a treatment legible.
When a biopsy is needed, and when it is not
A biopsy is not part of the assessment of an ordinary scar. It is reserved for specific situations, and knowing which ones helps a patient understand why it is being suggested:
- An ulcer within a scar that does not heal. A break in the surface that persists for weeks, particularly in a scar from a burn or a long-standing wound, is examined and sampled rather than treated as a slow-healing wound.
- A nodule in a scar that is growing or changing. A firm lump appearing within an old scar, or altering in size or character, is the second situation in which a sample is taken. A small number of skin tumours present in exactly this way.
- A scar that does not behave as a scar should. Where a lesion is not settling, is growing in a way the timeline does not explain, or looks unlike the other scars on the same person, sampling is how the question is answered.
Why this is stated rather than left implicit. These situations are uncommon and the reassurance is genuine, but only if the patient knows what they are. A scar that has been present for decades and then changes is not ordinary, and the reason to be seen is that it needs to be excluded.
How the findings become a plan
The assessment ends with a short statement rather than a list of options, and each element of it comes from something observed:
- The kind of scar. Hypertrophic, keloid, mature, contracture or a mixture. This decides whether the plan is non-surgical, whether an operation is appropriate at all, and what has to be done alongside an operation if one is used.
- Its maturity. Still changing or settled. This decides the timing, and in particular whether an operation is deferred while the tissue settles further.
- The symptom being treated, and what improvement would look like. Whether the target is itch, tightness, movement or appearance, together with the record taken at the first visit that the result will be compared against.
Why the plan states a target. The same treatment can be judged a success or a failure depending on what was being aimed at. Saying at the outset which symptom is being addressed, and what would count as a response, makes the next appointment a comparison rather than a fresh opinion.